Relationship between Poor Immunogenicity of HLA-A2-Restricted Peptide Epitopes and Paucity of Naïve CD8+ T-Cell Precursors in HLA-A2-Transgenic Mice
暂无分享,去创建一个
[1] M. Jenkins,et al. The Role of Naive T Cell Precursor Frequency and Recruitment in Dictating Immune Response Magnitude , 2012, The Journal of Immunology.
[2] W. Kang,et al. Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming. , 2011, Vaccine.
[3] T. Blankenstein,et al. Transgenic mice with a diverse human T cell antigen receptor repertoire , 2010, Nature Medicine.
[4] S. Green,et al. Altered effector functions of virus‐specific and virus cross‐reactive CD8+ T cells in mice immunized with related flaviviruses , 2010, European journal of immunology.
[5] G. Ahlenstiel,et al. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. , 2008, Gastroenterology.
[6] Bjoern Peters,et al. Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance1 , 2008, The Journal of Immunology.
[7] L. Lefrançois,et al. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. , 2008, Immunity.
[8] Marion Pepper,et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.
[9] L. Watkin,et al. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. , 2005, The Journal of clinical investigation.
[10] R. Welsh,et al. Private specificities of CD8 T cell responses control patterns of heterologous immunity , 2005, The Journal of experimental medicine.
[11] J. Sidney,et al. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes. , 2003, Human immunology.
[12] H. Spits. Development of αβ T cells in the human thymus , 2002, Nature Reviews Immunology.
[13] J. Hoofnagle,et al. Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 , 2002, The Journal of Immunology.
[14] P. Rohrlich,et al. Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. , 2002, International immunology.
[15] R. Bleackley,et al. Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.
[16] J. Bennink,et al. Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells , 2001, Journal of Virology.
[17] F. Chisari,et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.
[18] R. Bartenschlager,et al. Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. , 2001, Gastroenterology.
[19] F. Lemonnier,et al. H‐2 class I knockout, HLA‐A2.1‐transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies , 1999, European journal of immunology.
[20] A. Woods,et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. , 1998, Journal of immunology.
[21] J. Sidney,et al. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. , 1997, Journal of immunology.
[22] F. Lemonnier,et al. HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice , 1997, The Journal of experimental medicine.
[23] V. Engelhard,et al. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. , 1996, Journal of immunology.
[24] A. Vitiello,et al. Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic mice , 1996, European journal of immunology.
[25] H. Luthra,et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis , 1996, The Journal of experimental medicine.
[26] H. Inoko,et al. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4 , 1995, The Journal of experimental medicine.
[27] S. Martin,et al. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. , 1992, Journal of immunology.
[28] A. Vitiello,et al. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex , 1991, The Journal of experimental medicine.
[29] C. David,et al. Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes , 1990, The Journal of experimental medicine.
[30] R. Hardy,et al. Expression and function of HLA‐A2.1 in transgenic mice , 1989, European journal of immunology.
[31] P. Parham,et al. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. , 1989, Journal of immunology.
[32] Hergen Spits,et al. Development of alphabeta T cells in the human thymus. , 2002, Nature reviews. Immunology.
[33] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.